Author

Yadira Lobaina

Centro de Ingeniería Genética y BiotecnologíaORCID 0000-0003-0318-5111Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Research Focus:cell signaling & trafficking· 2 Research Focus:cell type annotation· 2 Organism:mouse· 2 Assay:proteomics· 2 Organism:non-human primate· 1

Frequent Co-Authors

Yasser PereraiD· 3 shared Diana Vázquez-BlomquistiD· 2 shared Lisset HermidaiD· 2 shared Rong Chen· 2 shared Changyuan Tan· 1 shared D. Urquiza· 1 shared E. Suzarte· 1 shared Edith SuzarteiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Yasser PereraORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivPreprintSep 4, 2026

Synthetic adjuvants to potentiate the immune response against rAg85B by nasal route.

Rong Chen, Changyuan Tan, Wen Li…·Yadira Lobaina

This study evaluates two synthetic adjuvants, ODN-39M and LALF32-51, for enhancing immune response against Mycobacterium tuberculosis Ag85B via nasal vaccination in mice, showing ODN-39M's effectiveness in inducing Th1 and mucosal immunity.

DOI 10.64898/2026.08.31.748287

mouseproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintMay 28, 2025

Immunological evaluation in African Green Monkeys of two nasal vaccine candidates to induce a broad immunity against coronaviruses

Laura Lazo, E. Suzarte, Diana Vázquez-Blomquist…·Lisset Hermida

This study evaluates two nasal coronavirus vaccines in African Green Monkeys, showing they induce cross-reactive immunity and neutralizing responses against SARS-CoV-2 and related coronaviruses.

DOI 10.1101/2025.05.28.656401

non-human primateexperimental assay

𝕏 PostBluesky

ImmunologybioRxivPreprintMay 9, 2025

A nasal vaccine candidate, based on S2 and N proteins from SARS-CoV-2, generates a broad antibody response systemic and at lower respiratory tract.

Yadira Lobaina, Rong Chen, Dania Vázquez‐Blomquist…·Lisset Hermida

This paper evaluates a nasal SARS-CoV-2 vaccine candidate based on S2 and N proteins, showing broad antibody responses and mucosal immunity in mice.

DOI 10.1101/2025.05.09.653001

mouseproteomics

𝕏 PostBluesky